HomeEarnings NewsBiocon Q3 earnings today: Here's what to expect

Biocon Q3 earnings today: Here's what to expect

Profile image

By Ekta Batra  January 24, 2019, 12:24:39 PM IST (Published)

Indian biopharmaceutical company Biocon is set to report its third quarter results on Thursday. Here are key factors to watch out for:


  • It is expected to be a strong quarter for the company.

  • The revenue is likely to grow around 30 percent.

  • Margin expansion of around 400 basis points seen, led by higher margin products. One basis point is a hundredth of a percentage point.

  • Profit is expected to see a growth of 79 percent.

  • Within the biosimilar business, the one thing which is going to drive growth will be the launch of Pegfilgrastim in the US, the cancer biosimilar.

  • Branded formulation segment is likely to follow biologics with strong growth of 20-25 percent.

Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!